Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR) (Q102055979)
Jump to navigation
Jump to search
scientific article published on 13 November 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR) |
scientific article published on 13 November 2020 |
Statements
Tumor mutation burden as a biomarker for lung cancer patients treated with pemetrexed and cisplatin (the JIPANG-TR) (English)
Takeharu Yamanaka
Toshiaki Takahashi
Haruko Daga
Tatsuo Ohira
Tsuyoshi Ueno
Tadashi Aoki
Kazuhiko Nakagawa
Koji Yamazaki
Yukio Hosomi
Koji Kawaguchi
Akimasa Sekine
Tomohiro Haruki
Yuki Sato
Hiroaki Akamatsu
Takashi Seto
Sho Saeki
Kenji Sugio
Kazunori Okabe
Nobuyuki Yamamoto
13 November 2020